THIS IS A SATELLITE SYMPOSIUM
The lack of current, formal didactic education regarding hemophilia and bleeding disorders management for physicians-in-training constitutes a major practice gap in real-world clinical practice. ER physicians are faced with significant challenges when encountering hemophilia patients in the ED, which may result in delays in instituting life and/or limb-saving therapies – often infusion of factor replacement therapy --- increasing potential for catastrophic bleeding. While patients with hemophilia are prone to medical emergencies, many ED’s do not have a hematologist on-call for consultation. However, the World Federation of Hemophilia treatment paradigm is to treat first, and then proceed with other indicated imaging or evaluatory tools. During this activity, the faculty will review common ER scenarios of hemophilia patients who come in for an urgent care visit, sharing best practices, with a goal of improving patient care.
EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
EXCEL Continuing Education designates this live activity for a maximum of 1 AMA/PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Physician Assistants: AAPA accepts AMA Category 1 Credit™ from organizations accredited by the ACCME.
• Nurse Practitioners: AANP accepts AMA Category 1 Credit™ from organizations accredited by the ACCME.
Dr. Davis has received a fee as a consultant for Bioverativ, Sanofi, and CSL Behring; a fee as an advisory board member for Bayer; and a fee as a speaker for Baxalta and Shire.
NOTE: This course is not accredited by SAEM. This course is accredited by EXCEL Continuing Education for VMP Genetics. It will not be included in CME certificate issued by SAEM.